Raltegravir (Isentress/MK-0518) and HIV-1 Infected CD4 Cells During Acute/Early HIV-1

NCT00781287 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Enrollment too slow.

Conditions

Human Immunodeficiency Virus

Interventions

DRUG: 3-drug anti-HIV therapy
DRUG: Raltegravir

Sponsor

University of Washington

Collaborators

[object Object]